8K filed today!
$Context Therapeutics (CNTX.US)$ On December 23, 2024, Context Therapeutics Inc. (the “Company”) sold 14,705,882 shares of its common stock, for aggregate gross proceeds of approximately $15 million. The shares were sold pursuant to a sales agreement with Leerink Partners LLC (the “Agent”) dated December 2, 2024. The Agent has informed the Company that the shares were purchased by MPM BioImpact LLC.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more1
Wonderful Day Mooooo : good or bad news?
Trytosaveabit OP Wonderful Day Mooooo : A bit of both!